Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges

por Elbers, L.P.B., Kastelein, J.J.P., Sjouke, B.
Publicado 2016

Familial Hypercholesterolemia: Present and Future Management

por Sjouke, B., Kusters, D. M., Kastelein, J. J. P., Hovingh, G. K.
Publicado 2011

The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins

por Friedrich, S, Kastelein, J J P, James, D, Waterhouse, T, Nissen, S E, Nicholls, S J, Krueger, K A
Publicado 2014

Triglycerides and Cardiovascular Risk

por Harchaoui, K.E.L, Visser, M.E, Kastelein, J.J.P, Stroes, E.S, Dallinga-Thie, G.M
Publicado 2009

Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes

por Kusters, D. M., Huijgen, R., Defesche, J. C., Vissers, M. N., Kindt, I., Hutten, B. A., Kastelein, J. J. P.
Publicado 2011

Genome-Wide Association Studies in Atherosclerosis

por Sivapalaratnam, S., Motazacker, M. M., Maiwald, S., Hovingh, G. K., Kastelein, J. J. P., Levi, M., Trip, M. D., Dallinga-Thie, G. M.
Publicado 2011

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

por Wijbrandts, C A, van Leuven, S I, Boom, H D, Gerlag, D M, Stroes, E G S, Kastelein, J J P, Tak, P P
Publicado 2008

Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus

por Nieuwdorp, M., Vergeer, M., Bisoendial, R. J., op ‘t Roodt, J., Levels, H., Birjmohun, R. S., Kuivenhoven, J. A., Basser, R., Rabelink, T. J., Kastelein, J. J. P., Stroes, E. S. G.
Publicado 2008

Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis

por Nieuwdorp, M., Holleman, F., de Groot, E., Vink, H., Gort, J., Kontush, A., Chapman, M. J., Hutten, B. A., Brouwer, C. B., Hoekstra, J. B. L., Kastelein, J. J. P., Stroes, E. S. G.
Publicado 2007

Loss of Function in Heparan Sulfate Elongation Genes EXT1 and EXT 2 Results in Improved Nitric Oxide Bioavailability and Endothelial Function

por Mooij, H. L., Cabrales, P., Bernelot Moens, S. J., Xu, D., Udayappan, S. D., Tsai, A. G., van der Sande, M. A. J., de Groot, E., Intaglietta, M., Kastelein, J. J. P., Dallinga‐Thie, G. M., Esko, J. D., Stroes, E. S., Nieuwdorp, M.
Publicado 2014